Author

Lucas Kampman

Fred Hutch Cancer CenterORCID 0000-0002-2008-549XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:biophysical modeling· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Helen Y. ChuiD· 2 shared Jesse D. BloomiD· 2 shared Aayushi J ShahiD· 1 shared Adam W. TurneriD· 1 shared Alex Harteloo· 1 shared Alexey KozlenkoviD· 1 shared Alia W. JohnsoniD· 1 shared Anna Elias-WarreniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Helen Y. ChuORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mutational constraints on RSV F and its neutralization by antibodies

Cassandra A. L. Simonich, Teagan E. McMahon, Gavin Juviler, Lucas Kampman, Helen Y. Chu, Jesse D. Bloom

This study defines how mutations in RSV F protein affect antibody neutralization and shows that resistance to nirsevimab is rare but possible.

Nature · Sep 16, 2026Peer-reviewedMicrobiology

Massive-scale single-nucleus multi-omics identifies novel rare noncoding drivers of Parkinson's disease

Shreya Menon, Adam W. Turner, Serena H. Chang, Alia W. Johnson, Heather H Chang, Aayushi J Shah, Youjie Zeng, Colleen E Strohlein, Lucas Kampman, Courtney M. Colston, Alexey Kozlenkov, Stella M. Dracheva, Micol Avenali, Giovanni Palermo, Roberto Ceravolo, , M. Ryan Corces

The paper identifies rare noncoding variants associated with Parkinson's disease using multi-omic data from over 3.3 million nuclei.

bioRxiv · Mar 5, 2026 · PreprintGenetics

Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants

Bernadeta Dadonaite, Sheri Harari, Brendan B. Larsen, Lucas Kampman, Alex Harteloo, Anna Elias-Warren, Helen Y. Chu, Jesse D. Bloom

This paper identifies spike mutations in recent SARS-CoV-2 variants that reduce neutralization by human antibodies and clinically relevant monoclonal antibodies, highlighting key sites and mechanisms affecting antigenicity and function.

Journal of Virology · Oct 13, 2025Peer-reviewedMicrobiology